Pharmascience Inc. launches pms-IRON SUCROSE for the Treatment of Iron Deficiency Anemia

Montreal, January 20, 2021 – Pharmascience is proud to launch pms-IRON SUCROSE, a generic drug with demonstrated bioequivalence to the brand name VENOFER® for the treatment of iron deficiency anemia in patients with chronic kidney disease. This product is the first generic product of its kind on the Canadian market.

Offering as the branded product, pms-IRON SUCROSE is available at a lower cost. This product manufactured in Canada by Pharmascience comes with a QR Code for additional product information.“We are very proud to be launching the only generic Iron Sucrose in Canada. Patients with chronic kidney disease can now have a more affordable solution. Pharmascience continues to invest in local Research and Development and local manufacturing, we are committed to reducing healthcare costs and increasing access, for all Canadians” declares Al Moghaddam, Vice President and General Manager of Pharmascience Canada.

ABOUT PHARMASCIENCE INC.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2020, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. Also, in 2020, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers.

Venofer is a registered trademark of Vifor Inc.

For product information, please contact Pharmascience’s Medical Information Department at 1-888-550-6060.